China’s drug maker WuXi AppTec reported record first-quarter revenue, as a robust order backlog and sustained demand from global pharmaceutical companies supported growth. For the three months ended March 31, the Shanghai- and Hong Kong-listed company posted revenue of 12.44 billion yuan (US$1.72 billion), up 28.81 per cent year on year, according to a filing released on Monday. Net profit climbed nearly 27 per cent to 4.65 billion yuan in the quarter. Both revenue and net profit exceeded market...
UPVOTERS
Community appreciation
See who found this content valuable and showed their support.
No upvotes yet.
Be the first to show your appreciation for this content.
TOPICS
Explore the same topics
Discover more content from the topics this post is mapped to.
Keep browsing
Explore more from this topic
Dive into the full feed of curated posts covering Automotive News & Trends.
Discussion
Be the first to comment
Add your perspective to get the discussion started.